Krystal Biotech (KRYS) Change in Account Payables (2016 - 2026)
Krystal Biotech (KRYS) reported Change in Account Payables of $1.0 million for Q1 2026, up 12.8% on a YoY basis from $906000.0 in Q1 2025, and up 658.47% sequentially from -$183000.0 in Q4 2025.
Krystal Biotech (KRYS) Change in Account Payables (2016 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 11 years of Change in Account Payables data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 12.8% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $942000.0 (down 20.84% YoY), and the FY2025 full-year result was $826000.0, down 18.3% from the prior year.
- Change in Account Payables grew to $1.0 million in Q1 2026, from -$183000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.1 million in Q2 2025 to a low of -$4.0 million in Q3 2025.
- A 5-year average of $88470.6 and a median of $91000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 579.44% in 2024 and slumped 4517.58% in 2025, its largest moves.
- Tracing KRYS's Change in Account Payables over 5 years: stood at -$938000.0 in 2022, then jumped by 76.33% to -$222000.0 in 2023, then slumped by 166.22% to -$591000.0 in 2024, then surged by 69.04% to -$183000.0 in 2025, then surged by 658.47% to $1.0 million in 2026.
- Business Quant data shows KRYS's Change in Account Payables at $1.0 million in Q1 2026, -$183000.0 in Q4 2025, and -$4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | -183,000.00 |
| Dec 31, 2025 | -183,000.00 |
| Sep 30, 2025 | -4.02 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 906,000.00 |
| Mar 31, 2025 | 906,000.00 |
| Dec 31, 2024 | -591,000.00 |
| Dec 31, 2024 | -591,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 784,000.00 |
| Jun 30, 2024 | 784,000.00 |
| Mar 31, 2024 | 727,000.00 |
| Mar 31, 2024 | 727,000.00 |
| Dec 31, 2023 | -222,000.00 |
| Dec 31, 2023 | -222,000.00 |